Hara T, Terakawa T, Okamura Y, Bando Y, et al. Real-world analysis of metastatic prostate cancer demonstrates increased frequency of PSA-imaging discordance with visceral metastases and upfront ARAT/docetaxel therapy. Prostate 2023 Jun 14. doi: 10.1002/pros.24588.
PMID: 37316357